The timing/schedule of data review usually based on enrollment 2/
The reason: mid-stream interruption of a trial might, by chance, be at a moment of exaggerated benefit 6/
Preventing infections is the goal, but that this is achieved w/o or w/ very low serious adverse effects 8/